List of Flex Databases Pharmacovigilance Customers
Prague, 170 00,
Czech Republic
Since 2010, our global team of researchers has been studying Flex Databases Pharmacovigilance customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Flex Databases Pharmacovigilance for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Flex Databases Pharmacovigilance for Clinical Trial Management include: Biotronik, a Germany based Healthcare organisation with 9000 employees and revenues of $1.10 billion, Harbor Clinical, a United States based Life Sciences organisation with 150 employees and revenues of $20.0 million, Palobiofarma Spain, a Spain based Life Sciences organisation with 25 employees and revenues of $1.0 million and many others.
Contact us if you need a completed and verified list of companies using Flex Databases Pharmacovigilance, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Flex Databases Pharmacovigilance customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Biotronik | Healthcare | 9000 | $1.1B | Germany | Flex Databases | Flex Databases Pharmacovigilance | Clinical Trial Management | 2025 | n/a |
In 2025, Biotronik selected Flex Databases Pharmacovigilance, part of Flex Databases' unified eClinical platform, to support Clinical Trial Management across its European operations. The selection was announced in November 2025 and targets consolidation of clinical trial safety workflows and centralized adverse event handling for Biotronik's clinical programs in Europe.
The implementation emphasizes the Pharmacovigilance module, delivering electronic safety case management, expedited reporting workflows, and aggregate safety reporting consistent with Clinical Trial Management requirements. Flex Databases Pharmacovigilance has been configured to manage case intake, medical coding, and regulatory reporting workflows, and to provide a single safety database for cross study visibility.
Deployment architecture follows a unified eClinical model, with the Pharmacovigilance capability embedded within Flex's platform to reduce data fragmentation between study systems and safety operations. Operational scope includes clinical operations, pharmacovigilance, and regulatory affairs teams across Biotronik's European sites, with role based access controls and audit trails implemented to support compliance and oversight.
Governance and rollout centered on standardizing safety case processing and defining centralized escalation and review workflows, enabling consistent case lifecycle management across studies. The vendor announcement cites streamlining clinical trial operations and realizing strong ROI across clinical processes in Europe, which frames the programmatic objectives for Biotronik's Flex Databases Pharmacovigilance deployment.
|
 |
Harbor Clinical | Life Sciences | 150 | $20M | United States | Flex Databases | Flex Databases Pharmacovigilance | Clinical Trial Management | 2025 | n/a |
In 2025 Harbor Clinical deployed Flex Databases Pharmacovigilance as its primary safety database platform. The implementation embeds Flex Databases Pharmacovigilance within Harbor Clinical's Clinical Trial Management environment to run pharmacovigilance operations across studies.
The deployment centers on the vendor's Flex PV module to support adverse event reporting, signal detection, and regulatory compliance workflows. Configured capabilities include centralized case intake and case management, coding and triage workflows, expedited reporting pipelines, and aggregate safety surveillance consistent with pharmacovigilance operations.
Operational coverage extends across clinical studies in North America and globally, with the platform supporting clinical operations, pharmacovigilance teams, and regulatory functions. Harbor Clinical uses the safety database to unify study-level safety data into a single operational repository for ongoing signal detection and reporting across programs.
Governance and process work focused on standardizing case processing and escalation workflows, enforcing audit trails and role-based access for safety reviewers and regulatory stakeholders. A vendor interview published October 2025 confirms Harbor Clinical's active use of the Flex PV module and describes improved operational efficiency following the implementation.
|
|
|
Palobiofarma Spain | Life Sciences | 25 | $1M | Spain | Flex Databases | Flex Databases Pharmacovigilance | Clinical Trial Management | 2025 | n/a |
In 2025, Palobiofarma Spain selected Flex Databases Pharmacovigilance to manage its pharmacovigilance safety/ICS R processes supporting an expanding clinical pipeline in Europe. The Flex Databases Pharmacovigilance deployment addresses Clinical Trial Management requirements by centralizing pharmacovigilance case handling and safety workflow orchestration for a small life sciences sponsor.
The announced implementation emphasizes the PV module as the core functional component, with configuration focused on case management, ICSR generation and tracking, expedited reporting workflows, and pharmacovigilance recordkeeping aligned to clinical trial oversight. Flex Databases Pharmacovigilance is described as the application to host those PV capabilities and to standardize PV operational workflows across studies.
Operational scope is explicitly European clinical activity and internal pharmacovigilance and clinical operations teams, reflecting Palobiofarma’s expanding pipeline and compact organizational scale. The announcement does not specify external system integrations or implementation partners, so integrations are not documented in the source.
The program was announced in February 2025, with a full PV module rollout expected within a year, indicating a staged implementation timeline with configuration and validation phases during the initial 12 months. Governance language in the announcement centers on centralized PV module use and phased rollout across study activities rather than detailed process reengineering.
|
Buyer Intent: Companies Evaluating Flex Databases Pharmacovigilance
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||